Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More
Xconomy
JULY 1, 2016
To boost the initiative, which aims to speed the pace of cancer research, FDA said it would consolidate its cancer review divisions under the Oncology Center of Excellence. But as Xconomy reported, details about the reorganization were scant, leaving open questions whether drug regulation actually needs to move faster.
Let's personalize your content